Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Pharmacovigilance Training in 2026: Courses, GVP Skills, and Certification

Strong pharmacovigilance programs build more than regulatory knowledge. This guide explains how to compare courses, develop GVP skills, strengthen inspection readiness, document competence, and connect training with real drug safety responsibilities across regulated pharmaceutical environments.
  • Blog, GMP
Pharmaceutical professional reviewing adverse event reporting, ICSR processing, signal detection, and compliance data on a digital interface.

EU Annex 11 in 2026 GMP Inspection Requirements for Data Integrity and Computerized Systems

This article explores computerized system compliance in pharmaceutical environments, focusing on validation lifecycle, audit trail integrity, and risk-based approaches. It highlights regulatory expectations for electronic records, system controls, and inspection readiness under EU GMP frameworks and GxP standards.
  • Blog, Computerized System Validation, GMP
Pharmaceutical data integrity ALCOA plus EU GMP with system access control and audit trail compliance requirements in regulated systems.

Pharmacovigilance history in 2026: Key Safety Milestones

This article explores pharmacovigilance history and its impact on modern inspection standards, while also addressing evolving drug safety systems, regulatory milestones, and how global pharmacovigilance salary trends reflect the growing complexity of compliance and risk management expectations.
  • Blog, GMP
Pharmacovigilance specialist reviewing drug safety data dashboards in a global compliance center reflecting pharmacovigilance salary trends, PV specialist salary insights, and regional pharmacovigilance jobs pay analysis

Key Differences Between GMP VS GLP Standards in Pharma in 2026

Explore this article to understand how GMP compliance and GLP compliance shape pharmaceutical operations. Learn about inspection drivers, lab quality controls, process validation, and cross-functional coordination to reduce risks and strengthen regulatory adherence in manufacturing and lab environments.
  • Blog, GMP
Pharma operations showing GMP inspection checklist, GLP protocol adherence, lab quality control, and documentation traceability in a compliant manufacturing and lab setup.

GMP documentation (GDocP) in 2026: inspection expectations and compliance controls

Strong documentation systems define inspection outcomes in pharmaceutical operations. This article explores how structured processes, data integrity principles, and consistent record management help organizations reduce compliance risks and maintain reliable, inspection-ready documentation across GMP-regulated environments.
  • Blog, GMP, Validation and Qualification
Pharmaceutical desk setup with checklist, medicines, and files representing pharmaceutical documentation practices and controlled record handling aligned with regulatory expectations.

good manufacturing practices in quality assurance in 2026: compliance and inspection controls

Quality assurance plays a central role in GMP compliance by controlling documentation, managing deviations, and ensuring CAPA effectiveness. This article explains how QA systems support inspection readiness and reduce regulatory risks across pharmaceutical manufacturing operations
  • Blog, GMP, Quality Management System
Pharmaceutical QA workspace displaying data integrity pharmaceutical manufacturing, deviation reports, and CAPA system controls in GMP operations.

Good Manufacturing Practices Example Explained in 2026

A clear operational example helps quality teams understand how compliance works in real pharmaceutical manufacturing. This article explains practical GMP scenarios, inspection expectations, and how documentation, deviation control, and production records demonstrate reliable manufacturing performance.
  • Blog, GMP, Quality Management System
Pharmaceutical production line where a quality specialist records data, demonstrating batch record documentation and operational control within a pharmaceutical quality system.

good manufacturing practices requirements in 2026: pharma compliance checklist

Pharmaceutical manufacturers must translate regulatory expectations into daily operational controls. This guide explains how GMP frameworks shape inspections, quality systems, and documentation practices while outlining the key compliance domains regulators evaluate during modern pharmaceutical manufacturing
  • Blog, GMP, Quality Management System
Pharmaceutical manufacturing facility inspection scene showing documentation review aligned with pharmaceutical manufacturing compliance requirements and GMP quality controls.

GMP Tools in 2026: Systems enabling inspection readiness

Pharmaceutical manufacturers increasingly rely on structured digital systems to manage quality oversight and regulatory compliance. This guide explains the operational tools that support monitoring, deviation control, CAPA workflows, and inspection readiness across modern pharmaceutical manufacturing environments.
  • Blog, Computerized System Validation, GMP
Pharmaceutical manufacturing environment using environmental monitoring software pharma and digital quality systems to track compliance data, manage investigations, and maintain inspection-ready manufacturing operations.

GMP environments in 2026: How inspectors assess control effectiveness

Environmental control plays a central role in pharmaceutical inspections. This article explains how early signals in monitoring data, governance gaps, and deviation patterns reveal weakening control systems and how organizations can strengthen environmental oversight to maintain regulatory compliance.
  • Blog, GMP, Validation and Qualification
Pharmaceutical cleanroom inspection showing environmental monitoring program review and sterile manufacturing conditions